Skip to main content
Clinical Trials/CTRI/2022/09/045492
CTRI/2022/09/045492
Not yet recruiting
Phase 3

A comparative study to evaluate the analgesic efficacy and safety of caudal versus intranasal dexmedetomidine as an adjuvant to caudal ropivacaine in paediatric patients undergoing infraumbilical surgeries : A Double blind randomised controlled study

All India Institute of Medical Sciences New Delhi0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
All India Institute of Medical Sciences New Delhi
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
All India Institute of Medical Sciences New Delhi

Eligibility Criteria

Inclusion Criteria

  • patient Aged 1\-8 years,ASA physical status I/II, undergoing infraumbilical surgeries under general anaesthesia

Exclusion Criteria

  • 1\.Parental /guardian refusal for inclusion in the study
  • 2\.Known allergy to amide local anaesthetics or dexmedetomidine.
  • 3\.Pre\-existing cardiovascular, respiratory or neurological disease
  • 4\.History of developmental delay or mental retardation which could make observational pain intensity assessment difficult
  • 5\.Children with conduction blocks
  • 6\.Known or suspected coagulopathy
  • 7\.Anatomical abnormalities of spine and sacrum.
  • 8\.Local infection at caudal puncture site
  • 9\.Rhinitis and nasal polyp
  • 10\.Patients with age \< 1 years and \>7 years

Outcomes

Primary Outcomes

Not specified

Similar Trials